CytomX Therapeutics
CTMX
CTMX
126 hedge funds and large institutions have $249M invested in CytomX Therapeutics in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 43 increasing their positions, 51 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
126
Holding in Top 10
–
Calls
$88K
Puts
–
Top Buyers
| 1 | +$13.2M | |
| 2 | +$2.25M | |
| 3 | +$1.92M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.45M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.15M |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$1.98M | |
| 3 | -$1.76M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
-$1.7M |
| 5 |
Renaissance Technologies
New York
|
-$1.57M |